15.03.2017 14:00:00

Mango Health Announces Partnership, Strategic Investment from Express Scripts

SAN FRANCISCO, March 15, 2017 /PRNewswire-USNewswire/ -- Mango Health, a mobile health company, today announced a long term operating partnership with Express Scripts (NASDAQ: ESRX) which will include a new daily health management platform to improve health outcomes. Through the partnership, Mango Health's innovative patient-facing mobile applications will be available to Express Scripts' clients, representing more than 85 million Americans. In addition to the operating partnership, Express Scripts has made a strategic investment in Mango Health.

"Our experience has taught us that when patients are active participants in their health, they achieve better health outcomes. Mango Health's success in keeping patients engaged in their care through fun, user-friendly mobile applications is a natural extension of the care our pharmacists provide to our members. We look forward to bringing together our unique capabilities to motivate patients and encourage positive and healthy behaviors," said Glen Stettin, Senior Vice President and Chief Innovation Officer at Express Scripts.

By integrating Mango Health's mobile applications with the Express Scripts platform and services, members of participating Express Scripts plans will enjoy:

  • A gamified approach that encourages positive behaviors that meaningfully improve outcomes for patients with their condition.
  • In-app support and advice from Express Scripts specialist pharmacists in more than 20 specialties, including diabetes, asthma and cancer.
  • The convenience of pre-populated medication lists and prescription refills within the Mango app.
  • Improved care coordination, medication safety and prescription drug affordability through customized alerts in the Mango app that are integrated with a patient's pharmacy plan, and offer information about medication adherence, possible medication safety concerns and cost-savings opportunities.

"Our track record of engaging patient populations daily, combined with Express Scripts' clinical expertise and commitment to patient-centered care, creates a unique opportunity for innovative programs that improve health outcomes," said Jason Oberfest, CEO at Mango Health. "We're honored to partner with one of the leaders in U.S. healthcare."

About Mango Health
Mango Health is a mobile health company that inspires those with chronic conditions to better manage their health each day. The Mango Health mobile platform encourages healthier, more productive individuals by fostering habits, knowledge and skills for better health and control of chronic disease. The Mango Health app for iPhone and Android has a 4.5 star user rating and has been continuously promoted by Apple as an outstanding personal care app for over three years.

For more information, visit mangohealth.com or follow @MangoHealth on Twitter.

About Express Scripts
Express Scripts puts medicine within reach of tens of millions of people by aligning with plan sponsors, taking bold action and delivering patient-centered care to make better health more affordable and accessible.

Headquartered in St. Louis, Express Scripts provides integrated pharmacy benefit management services, including network-pharmacy claims processing, home delivery pharmacy care, specialty pharmacy care, specialty benefit management, benefit-design consultation, drug utilization review, formulary management, and medical and drug data analysis services.  Express Scripts also distributes a full range of biopharmaceutical products and provides extensive cost-management and patient-care services.

For more information, visit Lab.Express-Scripts.com or follow @ExpressScripts on Twitter.

 

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/mango-health-announces-partnership-strategic-investment-from-express-scripts-300422863.html

SOURCE Mango Health

Nachrichten zu Express Scripts Holding Comehr Nachrichten

Keine Nachrichten verfügbar.

Analysen zu Express Scripts Holding Comehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!